HK1047138A1 - Bryostatins，bryopyrans and polyketides：構成與方法 - Google Patents

Bryostatins，bryopyrans and polyketides：構成與方法

Info

Publication number
HK1047138A1
HK1047138A1 HK02108798.5A HK02108798A HK1047138A1 HK 1047138 A1 HK1047138 A1 HK 1047138A1 HK 02108798 A HK02108798 A HK 02108798A HK 1047138 A1 HK1047138 A1 HK 1047138A1
Authority
HK
Hong Kong
Prior art keywords
bryopyrans
bryostatins
polyketides
compositions
methods
Prior art date
Application number
HK02108798.5A
Other languages
English (en)
Inventor
Haygood Margo
K Davidson Seana
W Allen Scott
Hildebrand Mark
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of HK1047138A1 publication Critical patent/HK1047138A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK02108798.5A 1999-08-04 2002-12-03 Bryostatins，bryopyrans and polyketides：構成與方法 HK1047138A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14728399P 1999-08-04 1999-08-04
PCT/US2000/021326 WO2001011024A2 (en) 1999-08-04 2000-08-04 Bryostatins, bryopyrans and polyketides: compositions and methods

Publications (1)

Publication Number Publication Date
HK1047138A1 true HK1047138A1 (zh) 2003-02-07

Family

ID=22520963

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02108798.5A HK1047138A1 (zh) 1999-08-04 2002-12-03 Bryostatins，bryopyrans and polyketides：構成與方法

Country Status (8)

Country Link
US (1) US20020081665A1 (zh)
EP (1) EP1212408A2 (zh)
JP (1) JP2003517817A (zh)
AU (1) AU6621500A (zh)
CA (1) CA2381290A1 (zh)
HK (1) HK1047138A1 (zh)
NZ (1) NZ516698A (zh)
WO (1) WO2001011024A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7256286B2 (en) 1999-11-30 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Bryostatin analogues, synthetic methods and uses
AU2003239594A1 (en) * 2002-05-20 2003-12-12 Christine Anderson Bryostatins, bryopyrans and polyketides: compositions and methods
US20070026488A1 (en) * 2005-07-27 2007-02-01 Targett Nancy M Biosynthesis of bryostatins by polyketide synthases (PKS)

Also Published As

Publication number Publication date
EP1212408A2 (en) 2002-06-12
JP2003517817A (ja) 2003-06-03
AU6621500A (en) 2001-03-05
WO2001011024A2 (en) 2001-02-15
CA2381290A1 (en) 2001-02-15
NZ516698A (en) 2004-03-26
US20020081665A1 (en) 2002-06-27
WO2001011024A3 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
AU2002217226A1 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
HUP0302128A3 (en) Anti-dual integrin antibodies, compositions, methods and uses
NL300390I2 (en) Anti-IL-12 antibodies, compositions, methods and uses
HUP0200811A2 (en) Solid composition, its producing and using
AU2002234076A1 (en) Construction composition, structure, and method
MXPA03005713A (es) Derivados de tetrahidropiridina, su preparacion y su uso como inhibidores de proliferacion celular.
AU2001241098A1 (en) Composition
AU6594401A (en) 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
HUP0300219A3 (en) Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
AU2001234178A1 (en) Modified bdnf
AU2001240791A1 (en) Sequence
AU2002223761A1 (en) Thickening composition
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
MXPA01000464A (es) Composicion.
AU2001275201A1 (en) Acne-treating composition
AU2001287852A1 (en) Composition
HK1047138A1 (zh) Bryostatins，bryopyrans and polyketides：構成與方法
HK1049485A1 (en) DithiepinoÄ6,5-BÜpyridines, and related compositions, methods of producing and uses.
AU2001250536A1 (en) Methods
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001211674A1 (en) Naphthomelanins, process for their preparation and compositions thereof
AU4667801A (en) Methods
AU2001284215A1 (en) Methods
AU2003239594A8 (en) Bryostatins, bryopyrans and polyketides: compositions and methods